Pharmaceutical Executive-08-01-2009

Dietary supplements function like drugs and are marketed like drugs. They should be regulated like ducks.

Pressure to expand healthcare puts drug pricing, marketing, and innovation on the negotiating table.

Business schools must prepare students for the post-recession economy, not teach them principles applicable to 2003.

With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.

In an era of blurred channels and information clutter, it is critical for brand managers to develop a unified strategy that bridges the gaps between audiences.

Through innovative patient compliance programs, manufacturers are taking steps to meet the needs of patients and the pharma industry.